LGD-4033, also known as Ligandrol, is a synthetic selective androgen receptor modulator (SARM) designed to selectively bind to androgen receptors in skeletal muscle and bone tissue. As an investigational… Read more
LGD-4033, also known as Ligandrol, is a synthetic selective androgen receptor modulator (SARM) designed to selectively bind to androgen receptors in skeletal muscle and bone tissue. As an investigational compound, it is primarily studied for its potential to promote anabolic activity while minimizing the androgenic side effects often associated with traditional steroids. Pharmaceutical and analytical laboratories require high-quality reference standards for this compound to conduct rigorous research and maintain regulatory compliance. This category includes the parent drug, associated impurities, and stable isotope labelled compounds essential for impurity profiling and quantitative analysis. By utilizing these precise reference materials, researchers can perform accurate method validation and quality control assays, ensuring the integrity of experimental data during the development and testing of selective androgen receptor modulators.